Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
Price
Gainers & Losers
Weekly Gainers & Losers
Monthly Gainers & Losers
Super/Mega Movers
Out & Under Performers
Advances & Declines
Only Buyers / Sellers
Value Toppers
Arbitrage Opportunity
New Highs / Lows
52 Week Highs / Lows
LifeTime Highs / Lows
Exchange Turnover
Historical Return
Exchange Holidays
Volume
Volume Toppers
Block Deals
Bulk Deals
Highest & Lowest Delivery
Delivery Shockers
Unusual Volume Up/Down
Exchange Volume
Analysis
5 Day's Up/Down
Rising VDP
Rising VD Fall in P
Price Shockers
Indian Indices
Profit Report
Income Report
Industry Performance
Market Turnover Scripwise
Sector Watch
Special Tools
Above Moving Avarage
Below Moving Avarage
Bullish Reversal
Gap Up
Gap Down
Higher Opening
Lower Opening
Stocks < Previous Highs
Stocks < Previous Low
  News Analysis
Hot Stocks
Other Market
Corporate News
Market Pulse
Economy
Company Result
FII Position
Opening Bell
Midday Review
Closing Bell
Stock News
Global News
  Corporate Action
BSE / NSE Announcements
Book Closures
Board Meetings
Bonus Issues
Dividend Details
Right Issues
Corporate Results
Delisted Shares
Split of Face Value
Change of Name
Mergers
Demergers
  Other Market
FII Investments
DII Investments
World Indices
ADR Prices
Forex
  Company Profile
Company Details
Smart Quote
Share Prices
Company Background
Board Members
MF Holdings
Company News
Peer Companies News
Financials
Profit & Loss
Balance Sheet
Cash Flow
Financial Ratios
Share Holdings Pattern
Results
Quaterly
Quick Review
Company Reports
Director's Report
Derivatives
IPO
BSE Company News
Glenmark Pharmaceuticals Ltd.
BSE Code 532296
ISIN Demat INE935A01035
Book Value (Rs) 868.32
NSE Code GLENMARK
Dividend Yield % 0.11
Market Cap(Rs Mn) 615635.17
TTM PE(x) 38.23
TTM EPS(Rs) 57.06
Face Value (Rs) 1  
Industry : Pharmaceuticals & Drugs
  
11-Jul-2025 Glenmark Pharmaceuticals’ arm enters into licensi...
11-Jul-2025 Glenmark Pharmaceuticals zooms as its arm enters ...
01-Jul-2025 Glenmark Pharmaceuticals informs about details of...
24-Jun-2025 Glenmark Pharmaceuticals launches TEVIMBRA in Ind...
24-Jun-2025 Glenmark Pharmaceuticals informs about media rele...
24-Jun-2025 Glenmark Pharmaceuticals rises on launching TEVIM...
19-Jun-2025 Glenmark Pharmaceuticals informs about disclosure
18-Jun-2025 USFDA concludes GMP inspection at Glenmark Pharma...
18-Jun-2025 Glenmark Pharmaceuticals informs about updates
18-Jun-2025 Glenmark Pharmaceuticals rises on the BSE
09-Jun-2025 Glenmark Pharmaceuticals to launch zanubrutinib i...
09-Jun-2025 Glenmark Pharmaceuticals informs about media rele...
26-May-2025 Glenmark Pharmaceuticals reports consolidated net...
22-May-2025 Intimation Of Grant Of Options Under 'Glenmark P...
19-May-2025 Glenmark Pharmaceutical informs about earnings ca...
Page 1 of 4
Prev || Next
Disclaimer  |  Privacy Policy  |  Rules and Regulation  |  Terms Of Use     Copyright 2008-2009 IITGROUP
Designed | Developed & Content Powered By www.accord.com ACCORD FINTECH